Influenza :: Novartis receives US government contract to develop a novel antigen technology

Novartis announced that it has received a contract from the US Department of Health and Human Services (HHS) of approximately USD 55 million. The contract supports the company’s efforts to bring the antigen-sparing capabilities of the MF59 adjuvant to the United States. An adjuvant is a substance added to a vaccine to enhance the body’s immune response to the vaccine’s active constituent, called the antigen.

Bird Flu :: Two birds tested for H5 virus – Hong Kong

Preliminary testing of two dead birds collected in Kowloon has indicated suspected cases of H5 avian influenza, a spokesman for the Agriculture, Fisheries and Conservation Department (AFCD) said today (January 18), adding that further confirmatory tests are being conducted.

Ear :: Treatment guidelines for ear infections

Researchers at Children?s Hospital of Pittsburgh of UPMC have launched a major National Institutes of Health-funded study to develop definitive treatment guidelines for the most common pediatric illness ? ear infections.

Influenza :: HHS Funds Advanced Development of H5N1 Influenza Vaccines

HHS Secretary Mike Leavitt announced today that the department has awarded contracts totaling $132.5 million to three vaccine makers for the advanced development of H5N1 influenza vaccines using an immune system booster called an adjuvant. An adjuvant is a substance that may be added to a vaccine to increase the body?s immune response to the vaccine?s active ingredient, called antigen.

Flu :: 1918 killer flu virus tested on monkeys

In a study of nonhuman primates infected with the influenza virus that killed 50 million people in 1918, an international team of scientists has found a critical clue to how the virus killed so quickly and efficiently.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack